questionsmedicales.fr
Phénomènes microbiologiques
Interactions microbiennes
Interactions microbiennes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysbiose
Analyse microbiologique
Séquençage ADN
Métagénomique
Diversité microbienne
Analyse statistique
Symptômes
5
Déséquilibre microbien
Troubles digestifs
Infection opportuniste
Symptômes
Allergies
Réponse immunitaire
Infections bactériennes
Signes cliniques
Prévention
5
Prévention des infections
Hygiène
Alimentation
Flore microbienne
Traitements
5
Antibiotiques
Antifongiques
Probiotiques
Santé intestinale
Antibiotiques
Flore microbienne
Immunomodulateurs
Réponse immunitaire
Complications
5
Infections chroniques
Système immunitaire
Infections opportunistes
Immunodéprimés
Santé mentale
Déséquilibres microbiens
Antibiotiques
Résistance bactérienne
Facteurs de risque
5
Facteurs de risque
Immunodépression
Médicaments
Flore microbienne
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interactions microbiennes : Questions médicales les plus fréquentes",
"headline": "Interactions microbiennes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interactions microbiennes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-01",
"dateModified": "2025-02-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interactions microbiennes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008827",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008827",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Détection du quorum",
"alternateName": "Quorum Sensing",
"url": "https://questionsmedicales.fr/mesh/D053038",
"about": {
"@type": "MedicalCondition",
"name": "Détection du quorum",
"code": {
"@type": "MedicalCode",
"code": "D053038",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G06.550.700"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Interactions microbiennes",
"alternateName": "Microbial Interactions",
"code": {
"@type": "MedicalCode",
"code": "D056265",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rachel J Dutton",
"url": "https://questionsmedicales.fr/author/Rachel%20J%20Dutton",
"affiliation": {
"@type": "Organization",
"name": "School of Biological Science, University of California San Diego, San Diego, 92093, USA. rjdutton@ucsd.edu."
}
},
{
"@type": "Person",
"name": "Ophelia S Venturelli",
"url": "https://questionsmedicales.fr/author/Ophelia%20S%20Venturelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706."
}
},
{
"@type": "Person",
"name": "Alan R Pacheco",
"url": "https://questionsmedicales.fr/author/Alan%20R%20Pacheco",
"affiliation": {
"@type": "Organization",
"name": "Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA."
}
},
{
"@type": "Person",
"name": "Daniel Segrè",
"url": "https://questionsmedicales.fr/author/Daniel%20Segr%C3%A8",
"affiliation": {
"@type": "Organization",
"name": "Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA."
}
},
{
"@type": "Person",
"name": "Kai Feng",
"url": "https://questionsmedicales.fr/author/Kai%20Feng",
"affiliation": {
"@type": "Organization",
"name": "CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008827"
},
{
"@type": "ListItem",
"position": 3,
"name": "Interactions microbiennes",
"item": "https://questionsmedicales.fr/mesh/D056265"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interactions microbiennes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interactions microbiennes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interactions microbiennes",
"description": "Comment diagnostiquer une dysbiose microbienne ?\nQuels tests sont utilisés pour identifier les interactions microbiennes ?\nQuels signes indiquent une infection microbienne ?\nComment évaluer la diversité microbienne ?\nQuels marqueurs biologiques sont utilisés pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interactions microbiennes",
"description": "Quels symptômes sont liés aux déséquilibres microbiens ?\nComment les interactions microbiennes affectent-elles la santé ?\nQuels symptômes indiquent une infection opportuniste ?\nLes allergies peuvent-elles être liées aux interactions microbiennes ?\nQuels signes cliniques sont associés aux infections bactériennes ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interactions microbiennes",
"description": "Comment prévenir les infections microbiennes ?\nLes probiotiques peuvent-ils prévenir les infections ?\nQuelles mesures d'hygiène sont recommandées ?\nComment l'alimentation influence-t-elle la santé microbienne ?\nLes vaccinations aident-elles à prévenir les infections ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interactions microbiennes",
"description": "Quels traitements sont efficaces contre les infections microbiennes ?\nComment les probiotiques influencent-ils les interactions microbiennes ?\nQuels sont les traitements pour la dysbiose ?\nLes antibiotiques affectent-ils la flore microbienne ?\nComment les traitements immunomodulateurs agissent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interactions microbiennes",
"description": "Quelles complications peuvent survenir avec une dysbiose ?\nComment les infections microbiennes peuvent-elles devenir chroniques ?\nQuels risques sont associés aux infections opportunistes ?\nLes déséquilibres microbiens peuvent-ils affecter la santé mentale ?\nQuelles complications peuvent résulter d'un traitement antibiotique inapproprié ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interactions microbiennes",
"description": "Quels facteurs augmentent le risque d'infections microbiennes ?\nComment le stress influence-t-il les interactions microbiennes ?\nL'alimentation joue-t-elle un rôle dans les infections ?\nQuels médicaments peuvent perturber la flore microbienne ?\nLes voyages peuvent-ils augmenter le risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D056265?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysbiose microbienne ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par analyse des échantillons microbiens et évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier les interactions microbiennes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture, séquençage ADN et métagénomique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection microbienne ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, inflammation, douleur et fatigue sont des signes courants d'infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer la diversité microbienne ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des méthodes de séquençage et d'analyse statistique."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont utilisés pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs incluent les cytokines, les métabolites et les biomarqueurs spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux déséquilibres microbiens ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent troubles digestifs, fatigue, et infections récurrentes."
}
},
{
"@type": "Question",
"name": "Comment les interactions microbiennes affectent-elles la santé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des maladies, influencer l'immunité et le métabolisme."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection opportuniste ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, éruptions cutanées et infections persistantes peuvent indiquer une infection opportuniste."
}
},
{
"@type": "Question",
"name": "Les allergies peuvent-elles être liées aux interactions microbiennes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent moduler la réponse immunitaire et provoquer des allergies."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux infections bactériennes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur sont des signes cliniques d'infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections microbiennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts à risque."
}
},
{
"@type": "Question",
"name": "Les probiotiques peuvent-ils prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les probiotiques peuvent renforcer la barrière intestinale et prévenir certaines infections."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle la santé microbienne ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fibres et en probiotiques favorise une flore microbienne saine."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations protègent contre certaines infections bactériennes et virales."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les infections microbiennes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques, antifongiques et antiviraux sont utilisés selon le type d'infection."
}
},
{
"@type": "Question",
"name": "Comment les probiotiques influencent-ils les interactions microbiennes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les probiotiques rétablissent l'équilibre microbien et améliorent la santé intestinale."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour la dysbiose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des probiotiques, prébiotiques et modifications alimentaires."
}
},
{
"@type": "Question",
"name": "Les antibiotiques affectent-ils la flore microbienne ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antibiotiques peuvent perturber la flore microbienne normale, causant des déséquilibres."
}
},
{
"@type": "Question",
"name": "Comment les traitements immunomodulateurs agissent-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils modifient la réponse immunitaire pour aider à contrôler les infections microbiennes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysbiose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies inflammatoires, allergies et infections chroniques."
}
},
{
"@type": "Question",
"name": "Comment les infections microbiennes peuvent-elles devenir chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent persister si le système immunitaire est affaibli ou mal géré."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés aux infections opportunistes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections opportunistes peuvent entraîner des complications graves, surtout chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Les déséquilibres microbiens peuvent-ils affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent un lien entre déséquilibres microbiens et troubles mentaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'un traitement antibiotique inapproprié ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela peut entraîner des résistances bactériennes et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infections microbiennes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le diabète, l'immunodépression et une mauvaise hygiène augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il les interactions microbiennes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut altérer la flore intestinale et affaiblir le système immunitaire."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les infections ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affaiblir l'immunité et favoriser les infections."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent perturber la flore microbienne ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques, les anti-inflammatoires et les immunosuppresseurs peuvent perturber la flore."
}
},
{
"@type": "Question",
"name": "Les voyages peuvent-ils augmenter le risque d'infections ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages exposent à de nouveaux agents pathogènes et augmentent le risque d'infections."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Biological Science, University of California San Diego, San Diego, 92093, USA. rjdutton@ucsd.edu.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706.
Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Graduate Program in Bioinformatics and Biological Design Center, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA.
Department of Biomedical Engineering, Department of Biology and Department of Physics, Boston University, 24 Cummington Mall, Boston, MA, 02215, USA.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Institute of Marine Science and Technology, Shandong University, Qingdao, China.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
Key Laboratory of Industrial Ecology and Environmental Engineering (MOE) and Dalian POCT Laboratory, School of Environmental Science and Technology, Dalian University of Technology, Dalian, China.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Institute of Marine Science and Technology, Shandong University, Qingdao, China.
CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China.
College of Resources and Environment, University of Chinese Academy of Sciences, Beijing, China.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Department of Biology, Boston College, Chestnut Hill, MA, 02467, USA. momeni@bc.edu.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Department of Plant & Microbial Biology, University of California, Berkeley, Berkeley, CA, USA. taga@berkeley.edu.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Department of Microbial Ecology, Netherlands Institute of Ecology (NIOO-KNAW), Wageningen, The Netherlands.
Publications dans "Interactions microbiennes" :
2 publications dans cette catégorie
Affiliations :
Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA. luting@illinois.edu.
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA. luting@illinois.edu.
Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL, USA. luting@illinois.edu.
Center for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA. luting@illinois.edu.
National Center for Supercomputing Applications, University of Illinois at Urbana-Champaign, Urbana, IL, USA. luting@illinois.edu.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA cmuzny@uabmc.edu.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Centre of Biological Engineering, Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho-Gualtar Campus, Braga, Portugal.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Centre of Biological Engineering, Laboratory of Research in Biofilms Rosário Oliveira (LIBRO), University of Minho-Gualtar Campus, Braga, Portugal.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publications dans "Interactions microbiennes" :
1 publication dans cette catégorie
Affiliations :
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publications dans "Interactions microbiennes" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...